Circulation Research, Vol 70, 1099-1103, Copyright © 1992 by American Heart Association

ARTICLES

Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Correlation of protection with preservation of glutathione levels

IT Mak, P Boehme and WB Weglicki
Department of Medicine, George Washington University Medical Center, Washington, D.C.

The effects of four calcium channel blockers (nicardipine, nifedipine, verapamil, and diltiazem) on free radical injury in cultured endothelial cells were studied and compared with those of butylated hydroxytoluene. When the cultured cells were exposed to a superoxide and hydroxyl radical generating system for up to 60 minutes, lipid peroxidation occurred, and cellular viability decreased by 60% at 30 minutes. Concomitantly, total cellular glutathione decreased by 40%, whereas total protein thiols changed minimally. Preincubation of the cells with each of the calcium blockers (5 and 20 microM) before free radical addition resulted in various degrees of significant protection against cell death, and losses of glutathione correlated significantly (r = 0.89, p less than 0.001). The order of efficacy was nicardipine greater than nifedipine greater than verapamil greater than diltiazem; butylated hydroxytoluene was about fourfold more potent than nicardipine. Because none of the agents affected the level of hydroxyl radicals generated in the aqueous phase, the data suggest that the protective mechanisms were mediated by their lipid antiperoxidative activities, which also prevented the glutathione decrease caused by inhibition of peroxide generation.

This article has been cited by other articles:

				T. Sugiura, T. Kondo, Y. Kureishi-Bando, Y. Numaguchi, O. Yoshida, Y. Dohi, G. Kimura, R. Ueda, T. J. Rabelink, and T. Murohara Nifedipine Improves Endothelial Function: Role of Endothelial Progenitor Cells Hypertension, September 1, 2008; 52(3): 491 - 498. [Abstract] [Full Text] [PDF]

				M. Iwai, H.-S. Li, R. Chen, T. Shiuchi, L. Wu, L.-J. Min, J.-M. Li, M. Tsuda, J. Suzuki, Y. Tomono, et al. Calcium Channel Blocker Azelnidipine Reduces Glucose Intolerance in Diabetic Mice via Different Mechanism Than Angiotensin Receptor Blocker Olmesartan J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1081 - 1087. [Abstract] [Full Text] [PDF]

				I. T. Mak, J. J. Chmielinska, L. Nedelec, A. Torres, and W. B. Weglicki D-Propranolol Attenuates Lysosomal Iron Accumulation and Oxidative Injury in Endothelial Cells J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 522 - 528. [Abstract] [Full Text] [PDF]

				R. C. Brown, K. S. Mark, R. D. Egleton, and T. P. Davis Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium Am J Physiol Cell Physiol, May 1, 2004; 286(5): C1045 - C1052. [Abstract] [Full Text] [PDF]

				T. Jinno, M. Iwai, Z. Li, J.-M. Li, H.-W. Liu, T.-X. Cui, H. Rakugi, T. Ogihara, and M. Horiuchi Calcium Channel Blocker Azelnidipine Enhances Vascular Protective Effects of AT1 Receptor Blocker Olmesartan Hypertension, February 1, 2004; 43(2): 263 - 269. [Abstract] [Full Text] [PDF]

				I. T. Mak and W. B. Weglicki Potent Antioxidant Properties of 4-Hydroxyl-propranolol J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 85 - 90. [Abstract] [Full Text] [PDF]

				S. Taddei, A. Virdis, L. Ghiadoni, D. Versari, G. Salvetti, A. Magagna, and A. Salvetti Calcium Antagonist Treatment by Lercanidipine Prevents Hyperpolarization in Essential Hypertension Hypertension, April 1, 2003; 41(4): 950 - 955. [Abstract] [Full Text] [PDF]

				M. Rathaus and J. Bernheim Oxygen species in the microvascular environment: regulation of vascular tone and the development of hypertension Nephrol. Dial. Transplant., February 1, 2002; 17(2): 216 - 221. [Abstract] [Full Text] [PDF]

				A. Gourine, A. Gonon, P.-O. Sjoquist, and J. Pernow Short-acting calcium antagonist clevidipine protects against reperfusion injury via local nitric oxide-related mechanisms in the jeopardised myocardium Cardiovasc Res, July 1, 2001; 51(1): 100 - 107. [Abstract] [Full Text] [PDF]

				S. Taddei, A. Virdis, L. Ghiadoni, A. Magagna, S. Favilla, A. Pompella, and A. Salvetti Restoration of Nitric Oxide Availability After Calcium Antagonist Treatment in Essential Hypertension Hypertension, March 1, 2001; 37(3): 943 - 948. [Abstract] [Full Text] [PDF]

				C. Napoli, S. Salomone, T. Godfraind, W. Palinski, D. M. Capuzzi, G. Palumbo, F. P. D'Armiento, R. Donzelli, F. de Nigris, R. L. Capizzi, et al. 1,4-Dihydropyridine Calcium Channel Blockers Inhibit Plasma and LDL Oxidation and Formation of Oxidation-Specific Epitopes in the Arterial Wall and Prolong Survival in Stroke-Prone Spontaneously Hypertensive Rats • Editorial Comment Stroke, September 1, 1999; 30(9): 1907 - 1915. [Abstract] [Full Text] [PDF]

				M. C. Verhaar, M. L.H. Honing, T. van Dam, M. Zwart, H. A. Koomans, J. J.P. Kastelein, and T. J. Rabelink Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids Cardiovasc Res, June 1, 1999; 42(3): 752 - 760. [Abstract] [Full Text] [PDF]

				T. Motoyama, H. Kawano, K. Kugiyama, O. Hirashima, M. Ohgushi, R. Tsunoda, Y. Moriyama, Y. Miyao, M. Yoshimura, H. Ogawa, et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1672 - 1679. [Abstract] [Full Text] [PDF]

				S. Taddei, A. Virdis, L. Ghiadoni, S. Uleri, A. Magagna, and A. Salvetti Lacidipine Restores Endothelium-Dependent Vasodilation in Essential Hypertensive Patients Hypertension, December 1, 1997; 30(6): 1606 - 1612. [Abstract] [Full Text]

				D. L. Wang, B.-S. Wung, Y.-J. Shyy, C.-F. Lin, Y.-J. Chao, S. Usami, and S. Chien Mechanical Strain Induces Monocyte Chemotactic Protein-1 Gene Expression in Endothelial Cells : Effects of Mechanical Strain on Monocyte Adhesion to Endothelial Cells Circ. Res., August 1, 1995; 77(2): 294 - 302. [Abstract] [Full Text]